Literature DB >> 12031728

Value of clinical and echocardiographic features in predicting outcome in the fetus, infant, and child with tetralogy of Fallot with absent pulmonary valve complex.

Anita J Moon-Grady1, Theresa A Tacy, Michael M Brook, Frank L Hanley, Norman H Silverman.   

Abstract

We describe clinical and echocardiographic features of tetralogy of Fallot with absent pulmonary valve complex (TOF/APVC) and hypothesized that outcome might be related to pulmonary artery enlargement or severity of illness. We examined the clinical records of all 23 patients evaluated at our institution before death or surgical correction of TOF/APVC between 1990 and 2000. Echocardiograms for 16 patients (including 5 fetuses) were also reviewed, and measurements of the semilunar valves and pulmonary arteries were obtained and compared with patient's aortic annulus size and with established normal subjects. Actuarial survival was 15 of 23 patients (68%) at 4 years. Four fetuses were hydropic and none survived; 7 patients were ventilator dependent at operation and only 3 survived. No difference was noted in pulmonary artery diameters in survivors versus nonsurvivors. Pulmonary valve annulus size was larger in nonsurvivors (103 +/- 25% vs 71 +/- 24% of normal, p = 0.03); however, when fetal examinations were excluded, this difference did not persist. Thus, only hydrops and ventilator dependence at diagnosis predicted mortality. There was no correlation between postnatal measurements of pulmonary arteries and outcome. Larger pulmonary annulus size in hydropic fetuses and poor survival among patients diagnosed in utero suggests that the pathophysiology in TOF/APVC is not due entirely to the aneurysmal dilation of the pulmonary arteries but may be related to right-sided cardiac dysfunction.

Entities:  

Mesh:

Year:  2002        PMID: 12031728     DOI: 10.1016/s0002-9149(02)02326-3

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  8 in total

1.  Prenatal diagnosis of a patient with tetralogy of Fallot and an absent pulmonary valve.

Authors:  Cemşit Karakurt; Gülendam Koçak; Ozlem Elkiran
Journal:  Pediatr Cardiol       Date:  2010-12-25       Impact factor: 1.655

2.  Three- and four-dimensional ultrasound in the diagnosis of fetal tetralogy of fallot with absent pulmonary valve and microdeletion 22q11.

Authors:  David Hartge; Ulrike Hoffmann; Andreas Schröer; Jan Weichert
Journal:  Pediatr Cardiol       Date:  2010-06-16       Impact factor: 1.655

3.  Atypical Circular Shunt and Diffuse Emphysema in a Fetus with Double-Outlet Right Ventricle and Absent Pulmonary Valve.

Authors:  Lindsay A Edwards; Prakash Masand; Shaine A Morris
Journal:  CASE (Phila)       Date:  2017-09-18

4.  Prenatal cardiac care: Goals, priorities & gaps in knowledge in fetal cardiovascular disease: Perspectives of the Fetal Heart Society.

Authors:  Nelangi M Pinto; Shaine A Morris; Anita J Moon-Grady; Mary T Donofrio
Journal:  Prog Pediatr Cardiol       Date:  2020-10-17

5.  Prenatal Diagnosis, Associations and Outcome for Fetuses with Congenital Absence of the Pulmonary Valve Syndrome.

Authors:  Kadir Babaoğlu; Yasemin Doğan; Sevcan Erdem; Nazan Özbarlas; Eviç Başar; Orhan Uzun
Journal:  Anatol J Cardiol       Date:  2022-09       Impact factor: 1.475

Review 6.  De novo 9q gain in an infant with tetralogy of Fallot with absent pulmonary valve: Patient report and review of congenital heart disease in 9q duplication syndrome.

Authors:  Ina E Amarillo; Shawn O'Connor; Caroline K Lee; Marcia Willing; Jennifer A Wambach
Journal:  Am J Med Genet A       Date:  2015-08-19       Impact factor: 2.802

7.  Sudden intrapartum fetal death in fetuses with absent pulmonary valve syndrome: report of two cases.

Authors:  Susan F Wilson; Geoffrey P Wong; Mark V Zilberman; Adam C Urato
Journal:  AJP Rep       Date:  2012-04-26

8.  Management and outcome of prenatal absent pulmonary valve syndrome.

Authors:  Florian Recker; Eva C Weber; Brigitte Strizek; Annegret Geipel; Christoph Berg; Ulrich Gembruch
Journal:  Arch Gynecol Obstet       Date:  2022-01-18       Impact factor: 2.493

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.